FDA’s Accelerated Approval Pathway: Separating Fact From Fiction October 20, 2021 Share this page The accelerated approval pathway is working as intended: delivering better health to those in dire need. We must value and protect it. Accelerated Approval Related Articles FDA Rare Disease Roundtable – June 3, 2026 June 04, 2026 Rare Disease Week 2026: Senate Hearing Recap February 27, 2026 FDA Takes Important Step Toward Individualized Therapies February 24, 2026 See All News